Abstract:Despite the advancement in screening and treatment strategies, colorectal cancer (CRC) remains the second leading cause of cancer-related mortality in the U.S., with significant disparities across racial/ethnic groups. Limited access to healthcare facilities and lower screening rates disproportionately affect Hispanics, leading to advanced-stage CRC diagnosis and subsequently lower overall survival rates. In a prior study using microarray and RNA-seq datasets from various databases, we identified 28 genes associated with stress-survival pathway (SSP) in CRC. The transcript-level expressions of these genes were analyzed in Hispanic (n=13) and NHW (n=19) tumors and corresponding non-tumor adjacent (NATs; Hispanic (n=5) and NHWs (n=6)) tissues by qRT-PCR. We observed that 14 SSP genes exhibited differential expression (BCL2L1, BCL2L12, CCNB1, CDK1, CSE1L, PDCD2L, ESPL1, GLA, GPX2, SLC7A11, TRIB3, NOXA, NQO1 and SH3GLB1) in CRC tissue samples from Hispanics compared to those from NHW individuals, suggesting their potential role in key cellular processes such as apoptosis regulation, cell cycle control, antioxidant defense, and cellular metabolism. BCL2L12, ESPL1, GPX1, NOXA, RRM2B, and SH3GLB1 were also differentially expressed in the Hispanic and NHW NATs; but their expression patterns differed in the respective tumor tissues suggesting their role in CRC development. With an increasing incidence of early-onset (individuals below 50 years) CRC cases, particularly known for its aggressive nature, and considering that Hispanics are the fastest-growing youngest ethnic group in the U.S., CRC disparities in Hispanics, is an extremely important problem to study. We further analyzed the expression patterns of SSP genes in early-onset (n=4) and late-stage (n=3) Hispanic CRC tissue samples compared to their respective NHW (early-onset (n=6); late-stage (n=11)) counterparts. Our study showed that eight genes (BCL2L12, CCNB1, CDC25, CDK1, GPX2, PRDX4, CSE1L, and NOXA) were differentially expressed in Hispanic CRC tissue from patients with an early-onset when compared to NHWs, suggesting their role cancer disparities especially related to early- onset of cancer among younger Hispanics individuals. Additionally, we observed the differential expression of three genes (MCM10, GPX2, and GLA) in late-stage Hispanic CRC tissues compared to NHWs indicating their potential role in the aggressiveness of late-stage CRC in the Hispanic population. Furthermore, we performed a functional analysis of the understudied gene MCM10 in CRC, which was differentially upregulated in Hispanic CRC tissues. Knockdown of MCM10 in two CRC cell lines (SW80 and Caco-2) revealed a significant decrease in various cellular processes including proliferation, invasion, migration, cell cycle, apoptosis, and ROS production. Our study suggests that certain SSP genes may have a role in Hispanic CRC disparities. Also, MCM10 plays a greater role in Hispanic CRC progression and has the potential to be used as an ethnicity-specific biomarker or therapeutic target for the Hispanic population. Citation Format: Sourav Roy, Urbashi Basnet, Md Zahirul Islam Khan. Unraveling the role of a stress-survival pathway gene MCM10 in Hispanic colorectal cancer disparities [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl) nr C104.

Abstract 1906: MSH3: An underestimated DNA MMR gene in colorectal carcinogenesis and its potential role in disparity

High-throughput sequencing and in-silico analysis confirm pathogenicity of novel MSH3 variants in African American colorectal cancer

Correlation between hMLH1-93G/A gene polymorphism and colorectal cancer

Germline Mutations in Chinese Colorectal Cancer Patients with Mismatch Repair Deficiency.

Abstract 3854: Revealing mismatch repair deficiency in Egyptian colorectal cancer patients using next generation sequencing a predictive biomarker for immunotherapy efficacy

The Prevalence of Germline Mutations in Chinese Colorectal Cancer Patients with Mismatch Repair Deficiency.

The Analysis for Identifying Large DNA Fragment Aberrations of MSH2 and MLH1 Genes from Familial Colorectal Cancer in China

MSH3-Deficiency Initiates EMAST without Oncogenic Transformation of Human Colon Epithelial Cells

Compound heterozygous MSH3 germline variants and associated tumor somatic DNA mismatch repair dysfunction

Abstract C104: Unraveling the role of a stress-survival pathway gene MCM10 in Hispanic colorectal cancer disparities

Abstract 7004: DNA Methylation analysis of African American colorectal cancers reveal race-specific alterations

Abstract LB410: Contrasting roles of different mismatch repair proteins in basal like breast cancer

Abstract 6469: The association of mismatch repair gene alterations with elevated tumor mutational burden in microsatellite stable gastrointestinal cancers

Abstract 3507: Mosaic chromosomal alterations in blood across ancestries via whole-genome sequencing

Abstract P6-01-28: Tangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers

Abstract 5615: Functional analysis of variants of uncertain significance in the MSH6 mismatch repair gene

The Human DNA Mismatch Repair Protein MSH3 Contains Nuclear Localization and Export Signals That Enable Nuclear-Cytosolic Shuttling in Response to Inflammation

Abstract 6845: MAGEA3 expression and secretion in MMR-MSH6 and MMR-PMS2 microsatellite-stable colorectal cancer

Abstract 7334: Germline mutations in cancer susceptibility genes in patients with mucosal melanoma

Lower degree of microsatellite instability in colorectal carcinomas from MSH6-associated Lynch syndrome patients

[Difference analysis of somatic mutations between deficient mismatch repair and proficient mismatch repair gene related with colorectal cancer]